-
Je něco špatně v tomto záznamu ?
Large language models for pretreatment education in pediatric radiation oncology: A comparative evaluation study
D. Wawrzuta, A. Napieralska, K. Ludwikowska, L. Jaruševičius, A. Trofimoviča-Krasnorucka, G. Rausis, A. Szulc, K. Pędziwiatr, K. Poláchová, J. Klejdysz, M. Chojnacka
Status neindexováno Jazyk angličtina Země Irsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2016
PubMed Central
od 2016
ROAD: Directory of Open Access Scholarly Resources
od 2016
- Publikační typ
- časopisecké články MeSH
BACKGROUND AND PURPOSE: Pediatric radiotherapy patients and their parents are usually aware of their need for radiotherapy early on, but they meet with a radiation oncologist later in their treatment. Consequently, they search for information online, often encountering unreliable sources. Large language models (LLMs) have the potential to serve as an educational pretreatment tool, providing reliable answers to their questions. We aimed to evaluate the responses provided by generative pre-trained transformers (GPT), the most popular subgroup of LLMs, to questions about pediatric radiation oncology. MATERIALS AND METHODS: We collected pretreatment questions regarding radiotherapy from patients and parents. Responses were generated using GPT-3.5, GPT-4, and fine-tuned GPT-3.5, with fine-tuning based on pediatric radiotherapy guides from various institutions. Additionally, a radiation oncologist prepared answers to these questions. Finally, a multi-institutional group of nine pediatric radiotherapy experts conducted a blind review of responses, assessing reliability, concision, and comprehensibility. RESULTS: The radiation oncologist and GPT-4 provided the highest-quality responses, though GPT-4's answers were often excessively verbose. While fine-tuned GPT-3.5 generally outperformed basic GPT-3.5, it often provided overly simplistic answers. Inadequate responses were rare, occurring in 4% of GPT-generated responses across all models, primarily due to GPT-3.5 generating excessively long responses. CONCLUSIONS: LLMs can be valuable tools for educating patients and their families before treatment in pediatric radiation oncology. Among them, only GPT-4 provides information of a quality comparable to that of a radiation oncologist, although it still occasionally generates poor-quality responses. GPT-3.5 models should be used cautiously, as they are more likely to produce inadequate answers to patient questions.
Department of Internal Diseases Riga Stradiņš University Dzirciema iela 16 LV 1007 Riga Latvia
Department of Radiation Oncology Riga East University Hospital Hipokrāta iela 2 LV 1038 Riga Latvia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25008325
- 003
- CZ-PrNML
- 005
- 20251126124249.0
- 007
- ta
- 008
- 250408e20250106ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ctro.2025.100914 $2 doi
- 035 __
- $a (PubMed)39867725
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Wawrzuta, Dominik $u Department of Radiation Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland
- 245 10
- $a Large language models for pretreatment education in pediatric radiation oncology: A comparative evaluation study / $c D. Wawrzuta, A. Napieralska, K. Ludwikowska, L. Jaruševičius, A. Trofimoviča-Krasnorucka, G. Rausis, A. Szulc, K. Pędziwiatr, K. Poláchová, J. Klejdysz, M. Chojnacka
- 520 9_
- $a BACKGROUND AND PURPOSE: Pediatric radiotherapy patients and their parents are usually aware of their need for radiotherapy early on, but they meet with a radiation oncologist later in their treatment. Consequently, they search for information online, often encountering unreliable sources. Large language models (LLMs) have the potential to serve as an educational pretreatment tool, providing reliable answers to their questions. We aimed to evaluate the responses provided by generative pre-trained transformers (GPT), the most popular subgroup of LLMs, to questions about pediatric radiation oncology. MATERIALS AND METHODS: We collected pretreatment questions regarding radiotherapy from patients and parents. Responses were generated using GPT-3.5, GPT-4, and fine-tuned GPT-3.5, with fine-tuning based on pediatric radiotherapy guides from various institutions. Additionally, a radiation oncologist prepared answers to these questions. Finally, a multi-institutional group of nine pediatric radiotherapy experts conducted a blind review of responses, assessing reliability, concision, and comprehensibility. RESULTS: The radiation oncologist and GPT-4 provided the highest-quality responses, though GPT-4's answers were often excessively verbose. While fine-tuned GPT-3.5 generally outperformed basic GPT-3.5, it often provided overly simplistic answers. Inadequate responses were rare, occurring in 4% of GPT-generated responses across all models, primarily due to GPT-3.5 generating excessively long responses. CONCLUSIONS: LLMs can be valuable tools for educating patients and their families before treatment in pediatric radiation oncology. Among them, only GPT-4 provides information of a quality comparable to that of a radiation oncologist, although it still occasionally generates poor-quality responses. GPT-3.5 models should be used cautiously, as they are more likely to produce inadequate answers to patient questions.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Napieralska, Aleksandra $u Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Wybrzeże Armii Krajowej 15, 44-100 Gliwice, Poland $u Department of Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Garncarska 11, 31-115 Cracow, Poland $u Faculty of Medicine & Health Sciences, Andrzej Frycz Modrzewski Krakow University, Gustawa Herlinga-Grudzińskiego 1, 30-705 Cracow, Poland
- 700 1_
- $a Ludwikowska, Katarzyna $u Department of Radiation Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland
- 700 1_
- $a Jaruševičius, Laimonas $u Oncology Institute, Lithuanian University of Health Sciences, A. Mickevičiaus g. 9, LT-44307, Kaunas, Lithuania
- 700 1_
- $a Trofimoviča-Krasnorucka, Anastasija $u Department of Radiation Oncology, Riga East University Hospital, Hipokrāta iela 2, LV-1038 Riga, Latvia $u Department of Internal Diseases, Riga Stradiņš University, Dzirciema iela 16, LV-1007 Riga, Latvia
- 700 1_
- $a Rausis, Gints $u Department of Radiation Oncology, Riga East University Hospital, Hipokrāta iela 2, LV-1038 Riga, Latvia
- 700 1_
- $a Szulc, Agata $u Department of Radiation Oncology, Lower Silesian Center of Oncology, Pulmonology and Hematology, Hirszfelda 12, 53-413 Wroclaw, Poland
- 700 1_
- $a Pędziwiatr, Katarzyna $u Department of Radiation Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland
- 700 1_
- $a Poláchová, Kateřina $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Žlutý kopec 7, 656 53 Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic $7 xx0280867
- 700 1_
- $a Klejdysz, Justyna $u Department of Economics, Ludwig Maximilian University of Munich (LMU), Geschwister-Scholl-Platz 1, 80539 Munich, Germany $u ifo Institute, Poschinger Straße 5, 81679 Munich, Germany
- 700 1_
- $a Chojnacka, Marzanna $u Department of Radiation Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland
- 773 0_
- $w MED00213969 $t Clinical and translational radiation oncology $x 2405-6308 $g Roč. 51 (20250106), s. 100914
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39867725 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250408 $b ABA008
- 991 __
- $a 20251126124235 $b ABA008
- 999 __
- $a ok $b bmc $g 2306340 $s 1245400
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 51 $c - $d 100914 $e 20250106 $i 2405-6308 $m Clinical and translational radiation oncology $n Clin Transl Radiat Oncol $x MED00213969
- LZP __
- $a Pubmed-20250408